Corpus Intelligence IC Memo — SPRINGFIELD HOSPITAL 2026-04-26 09:36 UTC
IC Memo — SPRINGFIELD HOSPITAL
Investment Committee Memorandum | VT | 25 beds | Grade D | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SPRINGFIELD HOSPITAL

CCN 471306 | WINDSOR, VT | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SPRINGFIELD HOSPITAL is a 25-bed rural/critical access in WINDSOR, VT with $49.5M in net patient revenue and a -17.0% operating margin. The hospital serves a payer mix of 60.0% Medicare, 11.1% Medicaid, and 28.9% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.0% to -9.6% (+736bps).

Net Revenue HCRIS$49.5M
Current EBITDA COMPUTED$-8.4M
Operating Margin COMPUTED-17.0%
Occupancy HCRIS38.4%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS42.2%
Distress Probability ML53.9%

2. Market Context & Competitive Position

16
VT Hospitals
-26.6%
State Median Margin
9
Comparable Hospitals

VT has 16 Medicare-certified hospitals with a median operating margin of -26.6%. The target's margin of -17.0% places it above the state median. Among 9 size-comparable peers (12-50 beds), the median margin is -29.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 9 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SPRINGFIELD HOSPITAL (Target)VT25$49.5M-17.0%
NORTHEASTERN VT REGIONAL HOPSIVT25$105.5M-7.7%
COPLEY HOSPITAL INC.VT25$91.4M-4.3%
BRATTLEBORO MEMORIAL HOSPITALVT47$78.9M-33.4%
PORTER HOSPITALVT25$78.1M-30.6%
NORTH COUNTRY HOSPITAL & HEALTVT25$70.8M-41.7%
MT ASCUTNEY HOSPITAL AND HEALTVT25$59.8M-8.6%
GIFFORD MEDICAL CENTERVT25$54.5M-29.1%
GRACE COTTAGE HOSPITALVT19$23.2M-32.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$989K+200bp12mo
Denial Rate Reduction12.0%6.5%$979K+198bp12mo
A/R Days Reduction5200.0%3800.0%$602K+122bp9mo
Clean Claim Rate88.0%96.0%$32K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$989K
Denial Rate Reduction
$979K
A/R Days Reduction
$602K
Clean Claim Rate
$32K
Total EBITDA Uplift$3.6M
Current EBITDA$-8.4M
+ RCM Uplift+$3.6M
Pro Forma EBITDA$-4.8M
Current Margin-17.0%
Pro Forma Margin-9.6%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.9M$-19.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.9M$-25.1M0.00x-100.0%
Bull Case9.0x11.0x$-11.6M$-17.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.6M$-22.3M0.00x-100.0%
Bear Case11.0x10.0x$-14.2M$-33.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-14.2M$-40.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 60.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 53.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 9 hospitals with 12-50 beds
  • Same-state prioritization (n=10)
  • Comp margins: P25=-32.6% / P50=-29.9% / P75=-8.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.